[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100622340":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":28,"locations":34,"responsibleParty":47,"collaborators":50,"id":53,"slug":54,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":59,"eligibilityCriteria":60,"healthyVolunteers":55,"sex":61,"minAge":62,"maxAge":12,"enrollmentInfo":63,"targetDuration":12,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":72,"overallStatus":75,"whyStopped":12,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":85},{"fullName":5,"class":6},"Vanderbilt University Medical Center","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Usual Care Group","NO_INTERVENTION","Care providers will treat subject per standard of care",null,{"label":14,"type":15,"description":16,"interventionNames":17},"Electronic Decision Aid Group","EXPERIMENTAL","the eMPOWER Decision Aid will be used to alert care providers to the patient specific recommendations for management of steatotic liver disease based on risk stratification",[18],"Other: eMPOWER Decision Aid",[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":12},"eMPOWER Decision Aid","An electronic health record embedded decision aid utilizing clinical data from both structured and unstructured clinical data to guide risk stratification and care management for patients with steatotic liver disease. Providers will be alerted to patient specific recommendations during the clinical encounter and between encounters through asynchronous communications related to subsequent testing.",[14],[25],{"name":26,"affiliation":5,"role":27},"Ashley Spann, MD, MSACI","PRINCIPAL_INVESTIGATOR",[29],{"name":30,"role":31,"phone":32,"phoneExt":12,"email":33},"Michael McGill","CONTACT","6153224643","michael.g.mcgill@vumc.org",[35],{"facility":5,"status":12,"city":36,"state":37,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":12},"Nashville","Tennessee","37232","United States","US",{"type":42,"coordinates":43},"Point",[44,45],-86.78444,36.16589,{"lat":45,"lon":44},{"type":27,"investigatorFullName":48,"investigatorTitle":49,"investigatorAffiliation":5,"oldNameTitle":12,"oldOrganization":12},"Ashley Spann","Assistant Professor, Transplant Hepatology",[51],{"name":52,"class":6},"American Association for the Study of Liver Diseases","100622340","a-study-of-electronic-clinical-decision-support-tools-for-steatotic-liver-disease-100622340",false,"NCT07382349","A Study of Electronic Clinical Decision Support Tools for Steatotic Liver Disease","Randomized Controlled Trial of Electronic Clinical Decision Support Systems for Improving Care Management and Clinical Outcomes for Adults With Steatotic Liver Disease","eMPOWER","Inclusion Criteria:\n\n* Adult patients (age ≥ 18 years)\n* Outpatient clinic visit (in-person or telemedicine) at a participating clinic site\n* Demonstrated Screening Need due to High Risk Profile, which includes the following: Diagnostic Codes for MASLD or Hepatic Steatosis on Imaging PLUS at least one cardiometabolic risk factors; OR Chronically Elevated Liver Enzymes (\\> 6 months); OR patient with impaired glycemic control (prediabetes\u002Fdiabetes); OR 2 or more cardiometabolic risk factors present\n\nExclusion Criteria:\n\n* Solid Organ Transplant Recipient\n* Existing Hepatology Relationship Evidenced by Prior Hepatology Visit Within 3 Years\n* Active Cancer Diagnoses\n* Diagnoses for Alcohol-Related Conditions\n* Pregnant Individuals\n* Receiving Palliative Care Services","ALL","18 Years",{"count":64,"type":65},7200,"ESTIMATED","INTERVENTIONAL",[68],"NA","The overall objectives of this study are to determine the effectiveness of a participant-specific guided electronic decision support system on provider decision making for participants with metabolic-dysfunction associated steatotic liver disease (MASLD), and to determine the acceptance and barriers for use of an electronic health record embedded algorithm for MASLD care management within ambulatory primary care, endocrinology, and general gastroenterology settings.",[71],"MASLD",[73,71,74],"Electronic Health Record","Clinical Decision Support","NOT_YET_RECRUITING","2026-01-31",{"date":78,"type":79},"2026-02-04","ACTUAL",{"date":81,"type":65},"2026-07",{"date":83,"type":65},"2030-02",{"name":5,"class":6},1]